Tissue-specific regulation of Apaf-1 expression by p53

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1139-1143

  Ho, Clement K ^a   Bush, Jason A ^a   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apaf 1; Gene expression; p53; Tumor suppressor

Indexed keywords

APAF1 PROTEIN, MOUSE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; MESSENGER RNA; PROTEIN; PROTEIN P53;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MOUSE MUTANT; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BLOTTING, WESTERN; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 2142744838     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1139     Document Type: Article

References (24)

1. Nunez G, Benedict MA, Hu Y and Inohara N: Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237-3245, 1998. (Pubitemid 29043976)
2. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413, 1997. (Pubitemid 27347231)
3. Moroni MC, Hickman ES, Denchi EZ, Caprara G, Colli E, Cecconi F, Müller H and Helin K: Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3: 552-558, 2001. (Pubitemid 32536851)
4. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW: Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284: 156-159, 1999. (Pubitemid 29282071)
5. Robles AI, Bemmels NA, Foraker AB and Harris CC: APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res 61: 6660-6664, 2001. (Pubitemid 32896481)
6. Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N and Givol D: DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 20: 3449-3455, 2001. (Pubitemid 32588994)
7. Hickman ES and Helin K: The regulation of APAF1 expression during development and tumourigenesis. Apoptosis 7: 167-171, 2002. (Pubitemid 34273132)
8. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS and Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221, 1992.
9. Li CQ, Trudel LJ and Wogan GN: Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc Natl Acad Sci USA 99: 10364-10369, 2002.
10. Fortin A, Cregan SP, MacLaurin JG, Kushwaha N, Hickman ES, Thompson CS, Hakim A, Albert PR, Cecconi F, Helin K, Park DS and Slack RS: APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J Cell Biol 155: 207-216, 2001. (Pubitemid 34289296)
11. Richardson H and Kumar S: Death to flies: Drosophila as a model system to study programmed cell death. J Immunol Methods 265: 21-38, 2002.
12. Ranger AM, Malynn BA and Korsmeyer SJ: Mouse models of cell death. Nat Genet 28: 113-118, 2001. (Pubitemid 32538050)
13. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
14. Smith ML and Seo YR: p53 regulation of DNA excision repair pathways. Mutagenesis 17: 149-156, 2002. (Pubitemid 34232906)
15. Hollstein M, Soussi T, Thomas G, von Brevern MC and Bartsch H: p53 gene alterations in human tumours: perspectives for cancer control. Recent Results Cancer Res 143: 369-389, 1997.
16. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409: 207-211, 2001. (Pubitemid 32144287)
17. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A and Donehower LA: p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53, 2002. (Pubitemid 34062443)
18. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA: Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7, 1994.
19. Webster KA, Discher DJ, Kaiser S, Hernandez O, Sato B and Bishopric NH: Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 104: 239-252, 1999.
20. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ and Kitsis RN: Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100: 1363-1372, 1997. (Pubitemid 27425760)
21. Jeremias I, Kupatt C, Martin-Villalba A, Habazettl H, Schenkel J, Boekstegers P and Debatin KM: Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 102: 915-920, 2000.
22. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K and Kitsis RN: Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 284: H456-H463, 2003. (Pubitemid 36142871)
23. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD and Helin K: E2Fs regulate the expression of gene involved in differentiation development, proliferation, and apoptosis. Genes Dev 15: 267-285, 2001. (Pubitemid 32155143)
24. Furukawa Y, Nishimura N, Furukawa Y, Satoh M, Endo H, Iwase S, Yamada H, Matsuda M, Kano Y and Nakamura M: Apaf-1 is a mediator of E2F-1-induced apoptosis. J Biol Chem 277: 39760-39768, 2002. (Pubitemid 35190959)